Abstract:The biological fate of polymeric micelles (PMs) following oral administration was investigated in this study to better understand the contribution of transport of integral PMs to oral absorption. To track integral PMs, near-infrared fluorophores with aggregation-caused quenching properties were utilized to label PMs comprised of methoxy poly(ethylene glycol)-poly(D,L-lactic acid) (mPEG-PDLLA) copolymers and methoxy poly(ethylene glycol)-distearoyl phosphoethanolamine (DSPE-PEG). The particle size of PMs prepared from mPEG2.5k-PDLLA1.25k, mPEG2.5k-PDLLA2.5k, mPEG5k-PDLLA3k, mPEG5k-PDLLA5k and DSPE-PEG2k was 24.5, 29.5, 34.0, 41.4 and 15.6 nm, respectively. After oral administration by gavage to rats, PMs were retained in the gastrointestinal tract for at least 4 h, and the copolymer block chain lengths did not have significant influence. The emergence of fluorescence in the blood and liver served as direct evidence to support oral absorption of integral PMs. Approximately 1–2% of intact particles were absorbed via the lymphatic pathway, but the total amount of PMs that reach the systemic circulation await further elucidation. Confocal laser scanning microscopy added more evidence to support the penetration of integral PMs into the basolateral tissues of microvilli. Cellular uptake efficiency was about 4–7% in Caco-2 cell lines for all PM groups, but was reduced to 1–3% in Caco-2/HT29-MTX co-culture models due to the hindrance by the mucus layers. Approximately 6–12% of integral PMs were transported across Caco-2/HT29-MTX/Raji monolayers, whereas only approximately one-tenth of that amount was transported across Caco-2 and Caco-2/HT29-MTX monolayers. Differences, but not statistically significant, were observed between PM groups in lymphatic uptake, biodistribution, cellular uptake and trans-monolayer transport, possibly owing to difference in block chain lengths as well as particle size. In conclusion, evidence obtained in this study supports penetration of integral PMs across the enteric epithelia, but the total amount may be limited.

Gastrointestinal lipolysis and trans-epithelial transport of SMEDDS via oral route

Oral Bioavailability and Lymphatic Transport of Pueraria Flavone-Loaded Self-Emulsifying Drug-Delivery Systems Containing Sodium Taurocholate in Rats.

Sophorolipid-based Microemulsion Delivery System: Multifaceted Enhancement of Physicochemical Properties of Xanthohumol.

Intestinal absorption studies of ORI-SMEDDS with different zeta potentials through lipolysis absorption model in vitro, single pass intestine perfusion and pharmacokinetics

Preparation, in Vivo and in Vitro Evaluation, and Pharmacodynamic Study of DMY‐Loaded Self‐Microemulsifying Drug Delivery System

Enhanced intestinal absorption of etoposide by self-microemulsifying drug delivery systems: roles of P-glycoprotein and cytochrome P450 3A inhibition.

A self-microemulsifying drug delivery system to overcome intestinal resveratrol toxicity and presystemic metabolism

Enhanced Bioavailability of Total Paeony Glycoside by Self-Microemulsifying Drug Delivery System.

Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems.

The biological fate of orally administered mPEG-PDLLA polymeric micelles

Self-Microemulsion Technology for Water-Insoluble Drug Delivery

Evaluation of the Cytotoxicity and Intestinal Absorption of a Self-Emulsifying Drug Delivery System Containing Sodium Taurocholate

Resveratrol Loaded Self-Microemulsifying Drug Delivery System (SMEDDS): Development and Optimization

Improved Oral Bioavailability of Myricitrin by Liquid Self-Microemulsifying Drug Delivery Systems

Self-microemulsifying drug-delivery system for improved oral bioavailability of 20(S)-25-methoxyl-dammarane-3β, 12β, 20-triol: preparation and evaluation

A New Strategy for Enhancing the Oral Bioavailability of Drugs with Poor Water-Solubility and Low Liposolubility Based on Phospholipid Complex and Supersaturated SEDDS

Mechanism investigation of ethosomes transdermal permeation.

Modulation of Lipid Digestibility Using Structured Emulsion-Based Delivery Systems: Comparison of in Vivo and in Vitro Measurements.

Development of Self-Emulsifying Drug Delivery Systems (SEDDSs) Displaying Enhanced Permeation of the Intestinal Mucus Following Sustained Release of Prototype Thiol-Based Mucolytic Agent Load

Size-Dependent Translocation of Nanoemulsions Via Oral Delivery

SEDDS facilitate cinnamaldehyde crossing the mucus barrier: The perspective of mucus and Caco-2/HT29 co-culture models